2002

May 29, 2002
Guidant Introduces New Therapy for Treating Postoperative Atrial Fibrillation

New Option Allows Early Intervention of Common Complication Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...

May 28, 2002
Guidant Announces Market Launch and First U.S. Implant of Advanced Pacemaker System

New Platform Offers Advanced Therapy, Comprehensive Patient Management and Ease-of-Use Features Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...

May 23, 2002
Influential Figures in Guidant's History Recognized for Lifesaving Invention

Inventors of the Implantable Defibrillator Honored by the National Inventors Hall of Fame Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

May 23, 2002
Guidant Announces Excellent Preliminary Results of Paclitaxel Eluting Stent Trial

DELIVER and ELUTES Data Continue to Support Benefit of Paclitaxel Eluting Stents Indianapolis, Ind. and Paris - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac...

May 22, 2002
Guidant Endovascular Solutions to Restructure

Company to Hold Mid-Quarter Call Today Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today...

Show 5102550100 per page
Top